We are live on
!
Find out more
KDA
KPCB DGF Associates Portfolio holdings
AUM
$58.3M
1-Year Est. Return
27.35%
This Fund
S&P 500
This Quarter
Est. Return
-31.53%
1 Year Est. Return
+27.35%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$129M
AUM Growth
-$48.9M
(-28%)
Cap. Flow
-$10.8M
Cap. Flow
% of AUM
-8.39%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teladoc Health
TDOC
|
+$10.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 54.97% |
| 2 | Consumer Discretionary | 38.37% |
| 3 | Financials | 6.66% |
| 4 | Healthcare | 0% |
Similar funds
SCC
BHIC
MMX
OCA
NCM
SRG
FWA
BSI
KPCB DGF Associates's Q2 2016 Portfolio in Review
As of Q2 2016, KPCB DGF Associates held 5 positions worth $129M, down 28% from $178M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
KPCB DGF Associates withdrew a net $10.8M in Q2 2016, closing 1 position. Its most notable exit was Teladoc Health, an estimated $10.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 55% of assets, up from 50% a quarter earlier, followed by Consumer Discretionary and Financials.
- KPCB DGF Associates fully exited Teladoc Health in Q2 2016, selling an estimated $10.8M.
- KPCB DGF Associates's ten largest holdings make up 100% of its $129M portfolio in Q2 2016.
- KPCB DGF Associates opened 0 new positions and closed 1 in Q2 2016.
- KPCB DGF Associates's portfolio value fell 28% quarter-over-quarter to $129M.
Based on KPCB DGF Associates's 13F filing for Q2 2016, filed 8 Jul 2016.